Dynamix Pharmaceuticals Revenue

Pharmaceutical Manufacturing • Rehovot, Center District, Israel • 1-10 Employees

Dynamix Pharmaceuticals revenue & valuation

Annual revenue	$427,775
Revenue per employee	$86,000
Estimated valuation?This valuation is estimated based on industry average for the Pharmaceutical Manufacturing industry and current estimated revenues	$1,400,000
Total funding	No funding

Key Contact at Dynamix Pharmaceuticals

Oren Becker

President and CEO

Company overview

Headquarters	13 Gad Feinstein Rd., Rehovot, 76385, IL
Website	dynxp.com
NAICS	3254
Founded	2009
Employees	1-10

About Dynamix Pharmaceuticals

Dynamix is a venture-backed drug discovery and development company focused on cancer and autoimmune disorders. The company’s platform technology, DynamixFit™, is uniquely suitable for discovering novel small-molecule Type II kinase inhibitors that carry the promise of better clinical profiles. Dynamix has created a pipeline of proprietary novel products, and expects to start clinical development in 2011

Employees by Management Level

Total employees: 1-10

Seniority

Employees

C-Suite

Employees by Department

Dynamix Pharmaceuticals has 1 employees across 1 departments.

Departments

Number of employees

Funding Data

Dynamix Pharmaceuticals has never raised funding before.

Frequently asked questions

Dynamix Pharmaceuticals is located in Rehovot, Center District, IL.

Dynamix Pharmaceuticals generates an estimated annual revenue of $427,775. This revenue figure reflects the company's market position and business performance in its industry.

Dynamix Pharmaceuticals has an estimated valuation of $1,400,000. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.

Dynamix Pharmaceuticals was founded in 2009, making it 17 years old. The company has established itself as a significant player in its industry over this time.

Dynamix Pharmaceuticals has approximately 1-10 employees. The company continues to grow its workforce to support its business operations and expansion.

Key Contact at Dynamix Pharmaceuticals

Oren Becker

President and CEO

4.8

40,000 users